Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.51 USD | +0.30% | +5.57% | +37.85% |
May. 09 | Wedbush Raises Price Target on Revolution Medicines to $46 From $42, Maintains Outperform Rating | MT |
May. 08 | Revolution Medicines Q1 Net Loss Narrows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.85% | 6.5B | |
+33.15% | 49.46B | |
+2.02% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+12.07% | 26.61B | |
-22.58% | 18.64B | |
+8.32% | 13.16B | |
+30.32% | 12.55B | |
+24.00% | 12.1B |
- Stock Market
- Equities
- RVMD Stock
- News Revolution Medicines, Inc.
- Revolution Medicines Insider Sold Shares Worth $239,123, According to a Recent SEC Filing